Acurx Pharmaceuticals, Inc. — Investor Relations & Filings
Filings indexed
211
across all filing types
Latest filing
2026-05-12
Regulatory Filings
Country
US
United States of America
Listing
US
ACXP
Acurx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing a new class of antibiotics. The company's therapeutic candidates are designed to treat infections caused by bacteria designated as priority pathogens by organizations such as the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC). Acurx's approach involves developing antibiotics that inhibit a novel molecular target previously unexploited in medical research. A primary focus of its clinical development is the treatment of Clostridioides difficile Infection (CDI).
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 424B3 - Acurx Pharmaceuticals, Inc. (0001736243) (Filer) | 2026-05-12 | English | |
| 424B3 - Acurx Pharmaceuticals, Inc. (0001736243) (Filer) | 2026-05-12 | English | |
| S-1 - Acurx Pharmaceuticals, Inc. (0001736243) (Filer) | 2026-05-04 | English | |
| 8-K - Acurx Pharmaceuticals, Inc. (0001736243) (Filer) | 2026-04-16 | English | |
| 424B5 - Acurx Pharmaceuticals, Inc. (0001736243) (Filer) | 2026-04-16 | English | |
| 424B3 Filing | 2026-02-11 | English |
Browse filings by year
9 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
8 filings
| |||||
| 45338325 | 424B3 - Acurx Pharmaceuticals, Inc. (0001736243) (Filer) | 2026-05-12 | English | ||
| 45338260 | 424B3 - Acurx Pharmaceuticals, Inc. (0001736243) (Filer) | 2026-05-12 | English | ||
| 41041919 | S-1 - Acurx Pharmaceuticals, Inc. (0001736243) (Filer) | 2026-05-04 | English | ||
| 34647178 | 8-K - Acurx Pharmaceuticals, Inc. (0001736243) (Filer) | 2026-04-16 | English | ||
| 34647177 | 424B5 - Acurx Pharmaceuticals, Inc. (0001736243) (Filer) | 2026-04-16 | English | ||
| 31526040 | 424B3 Filing | 2026-02-11 | English | ||
| 31526014 | S-1 Filing | 2026-02-02 | English | ||
| 13101932 | Regulatory Filings 2026 | 2026-01-07 | English | ||
|
2025
7 filings
| |||||
| 13101933 | FORM S-3/A | 2025-12-30 | English | ||
| 13101935 | Major Shareholding Notification 2025 | 2025-11-15 | English | ||
| 13101934 | 10-Q | 2025-11-12 | English | ||
| 13101936 | 424B3 | 2025-11-10 | English | ||
| 13101937 | FORM S-1 | 2025-10-20 | English | ||
| 13101938 | FORM 8-K | 2025-09-22 | English | ||
| 13101939 | FORM 8-K | 2025-09-19 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Antibiotice S.A.
Pharmaceutical firm manufacturing generic medicines, anti-i…
|
ATB | RO | Manufacturing |
|
Anuh Pharma Ltd.
Manufacturer of APIs and bulk drugs specializing in Macroli…
|
ANUHPHR | IN | Manufacturing |
|
Apellis Pharmaceuticals, Inc.
Biopharmaceutical company developing therapies by targeting…
|
APLS | US | Manufacturing |
|
Apeloa Pharmaceutical Co.,Ltd.
Integrated provider of APIs, CDMO services, and finished dr…
|
000739 | CN | Manufacturing |
|
APEX HEALTHCARE BERHAD
Integrated pharmaceutical group manufacturing and distribut…
|
— | MY | Manufacturing |
|
ApicHope Pharmaceutical Group Co.,Ltd
Pharmaceutical firm focused on pediatric, chronic, and card…
|
300723 | CN | Manufacturing |
|
Apimeds Pharmaceuticals US, Inc.
Clinical-stage biopharma developing a bee venom drug and AI…
|
APUS | US | Manufacturing |
|
Apogee Therapeutics, Inc.
Clinical-stage biotech developing biologics for immunologic…
|
APGE | US | Manufacturing |
|
Apollomics Inc.
Clinical-stage biotech developing innovative oncology and c…
|
APLM | US | Manufacturing |
|
Apontis Pharma AG
Develops and markets fixed-dose combination drugs (Single P…
|
APPH | DE | Manufacturing |
Acurx Pharmaceuticals, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35349/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35349 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35349 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35349 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35349}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Acurx Pharmaceuticals, Inc. (id: 35349)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.